title: Mechanisms of tizanidine action on spasticity.
abstract: This investigation estimated the mechanisms of tizanidine action on spasticity using a battery of neurophysiological methods. Thirty patients with old post-stroke spastic hemiparesis took part in the investigation. They were treated with tizanidine-mean daily dose 15.8 +/- 5.6 mg for a mean of 23.3 +/- 4.8 days. A questionnaire for assessment of subjective improvement after treatment used a 5-point scale. For standardization of the neurological examination 5-point scales were used to assess muscle tone, muscle force and tendon reflexes. A battery of neurophysiological methods was used to analyze different mechanisms of spasticity: for alpha motoneuron excitability--the F wave parameters; for presynaptic inhibition--the ratio of H reflex amplitudes before and after vibration of the achilles tendon (Hvibr/Hmax); for common interneuron activity--the flexor reflex parameters. Our results revealed that tizanidine reduces spastically increased muscle tone, but has no influence on muscle force, tendon reflexes, Babinski sign and ankle clonus. Tizanidine is supposed to act by increasing the presynaptic inhibition and decreasing of alpha motoneuron excitability. When spasticity has decreased presynaptic inhibition and increased motoneuron excitability, it is better to treat with tizanidine.
authors.affiliation: University Hospital, IV kilometer, III Neurological Clinic, Sofia, Bulgaria.
authors.forename: I
authors.initials: I
authors.lastname: Milanov
authors.forename: D
authors.initials: D
authors.lastname: Georgiev
mesh_terms: D000328:Adult; D000368:Aged; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003000:Clonidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004576:Electromyography / Q000187:drug effects; D005260:Female; D006181:H-Reflex / Q000187:drug effects; D006429:Hemiplegia / Q000188:drug therapy*; D006801:Humans; D007395:Interneurons / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009046:Motor Neurons / Q000187:drug effects; D009125:Muscle Relaxants, Central / Q000008:administration & dosage* / Q000009:adverse effects; D009128:Muscle Spasticity / Q000188:drug therapy*; D009433:Neural Inhibition / Q000187:drug effects; D009460:Neurologic Examination / Q000187:drug effects*
chemical_list: D009125:Muscle Relaxants, Central; C023754:tizanidine; D003000:Clonidine